SA

Suneela Ashok Paigankar

Active Director Director DIN 01104810
DIN 01104810 First appointment Jul 1995 Primary industry Business Outsourcing
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 1995
Shareholding value •••• Premium profile

About Suneela Ashok Paigankar

Data last updated:

Suneela Ashok Paigankar is a Director at Nurexa Pharma Private Limited (since 1995). The company operates in Business Outsourcing. Nurexa Pharma Private Limited reported revenue of ₹9.47 Cr (FY 2025).

DIN 01104810
Primary Designation Director
Industry Business Outsourcing
First Appointment 27 Jul 1995
Oldest Company Age 31 yrs
Largest company Nurexa Pharma Private Limited · ₹9.47 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nurexa Pharma Private Limited U24230MH1995PTC091080
Director27 Jul 19951995₹9.47 Cr (FY 2025)Active

Board colleagues of Suneela Ashok Paigankar

Directorship timeline

Open interactive timeline →
Nurexa Pharma Private Limited
Premium access

Shareholding and investment profile for Suneela Ashok Paigankar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suneela Ashok Paigankar

Suneela Ashok Paigankar currently holds 1 directorship: Nurexa Pharma Private Limited (Director, since 27 Jul 1995, revenue ₹9.47 Cr (FY 2025)).

Suneela Ashok Paigankar was first appointed on 27 Jul 1995 as Director at Nurexa Pharma Private Limited.

The current boards of Suneela Ashok Paigankar's companies include Sameer Ashok Paigankar (Nurexa Pharma Private Limited), Sheela Sameer Paigankar (Nurexa Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available